Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/26093
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDomingues, TD-
dc.contributor.authorGrabowska, AD-
dc.contributor.authorLee, JS-
dc.contributor.authorAmeijeiras-Alonso, J-
dc.contributor.authorWestermeier, F-
dc.contributor.authorScheibenbogen, C-
dc.contributor.authorCliff, JM-
dc.contributor.authorNacul, L-
dc.contributor.authorLacerda, EM-
dc.contributor.authorMouriño, H-
dc.contributor.authorSepúlveda, N-
dc.date.accessioned2023-03-09T10:36:24Z-
dc.date.available2023-03-09T10:36:24Z-
dc.date.issued2021-07-05-
dc.identifierORCID iDs: Ji-Sook Lee https://orcid.org/0000-0003-1747-9700; Jacqueline M Cliff https://orcid.org/0000-0002-5653-1818.-
dc.identifier686736-
dc.identifier.citationDomingues, T.D. et al. (2021) 'Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank', Frontiers in Medicine, 8, 686736, pp. 1 - 11. doi: 10.3389/fmed.2021.686736.en_US
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/26093-
dc.descriptionData Availability Statement: The raw data supporting the conclusions of this paper will be made available from Eliana M. Lacerda upon request.en_US
dc.description.abstractCopyright © 2021 Domingues, Grabowska, Lee, Ameijeiras-Alonso, Westermeier, Scheibenbogen, Cliff, Nacul, Lacerda, Mouriño and Sepúlveda The evidence of an association between Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and chronic herpesviruses infections remains inconclusive. Two reasons for the lack of consistent evidence are the large heterogeneity of the patients' population with different disease triggers and the use of arbitrary cutoffs for defining seropositivity. In this work we re-analyzed previously published serological data related to 7 herpesvirus antigens. Patients with ME/CFS were subdivided into four subgroups related to the disease triggers: S0-42 patients who did not know their disease trigger; S1-43 patients who reported a non-infection trigger; S2-93 patients who reported an infection trigger, but that infection was not confirmed by a lab test; and S3-48 patients who reported an infection trigger and that infection was confirmed by a lab test. In accordance with a sensitivity analysis, the data were compared to those from 99 healthy controls allowing the seropositivity cutoffs to vary within a wide range of possible values. We found a negative association between S1 and seropositivity to Epstein-Barr virus (VCA and EBNA1 antigens) and Varicella-Zoster virus using specific seropositivity cutoff. However, this association was not significant when controlling for multiple testing. We also found that S3 had a lower seroprevalence to the human cytomegalovirus when compared to healthy controls for all cutoffs used for seropositivity and after adjusting for multiple testing using the Benjamini-Hochberg procedure. However, this association did not reach statistical significance when using Benjamini-Yekutieli procedure. In summary, herpesviruses serology could distinguish subgroups of ME/CFS patients according to their disease trigger, but this finding could be eventually affected by the problem of multiple testing.en_US
dc.description.sponsorshipTD, HM, and NS were partially funded by the Fundação para a Ciência e a Tecnologia, Portugal (ref: UIDB/00006/2020 and UIDB/04561/2020). NS, EL, and CS were partially funded by ME Research UK (SCIO Charity Number SC036942) with the financial support of The Fred and Joan Davies Bequest. TD also received travel funding from the EUROMENE Cost Action (ref. CA15111) for a short scientific mission to the London School of Hygiene & Tropical Medicine in 2018. JA-A acknowledged the financial support of the Project MTM2016-76969-P from the Spanish State Research Agency (AEI) co-funded by the European Regional Development Fund (ERDF), the Competitive Reference Groups 2017-2020 (ED431C 2017/38) from the Xunta de Galicia through the ERDF. The UK ME/CFS Biobank was established with a joint grant from the charities ME Association (including continuing support), ME Research UK and Action for ME, as well as private donors. Research reported in this manuscript was supported by the National Institutes of Health (NIH) under award number 2R01AI103629.en_US
dc.format.extent1 - 11-
dc.format.mediumElectronic-
dc.language.isoen_USen_US
dc.publisherFrontiers Mediaen_US
dc.rightsCopyright © 2021 Domingues, Grabowska, Lee, Ameijeiras-Alonso, Westermeier, Scheibenbogen, Cliff, Nacul, Lacerda, Mouriño and Sepúlveda. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectdisease triggeren_US
dc.subjectcutoff valueen_US
dc.subjectstratificationen_US
dc.subjectEpstein-Barr virusen_US
dc.subjecthuman cytomegalovirusen_US
dc.subjectvaricella-zoster virusen_US
dc.subjecthuman herpesvirus-6en_US
dc.subjectherpes simplex virus 1 and 2en_US
dc.titleHerpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobanken_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.3389/fmed.2021.686736-
dc.relation.isPartOfFrontiers in Medicine-
pubs.publication-statusPublished-
pubs.volume8-
dc.identifier.eissn2296-858X-
dc.rights.holderDomingues, Grabowska, Lee, Ameijeiras-Alonso, Westermeier, Scheibenbogen, Cliff, Nacul, Lacerda, Mouriño and Sepúlveda-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2021 Domingues, Grabowska, Lee, Ameijeiras-Alonso, Westermeier, Scheibenbogen, Cliff, Nacul, Lacerda, Mouriño and Sepúlveda. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.1.67 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons